1. Home
  2. PTIX vs GNLN Comparison

PTIX vs GNLN Comparison

Compare PTIX & GNLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PTIX
  • GNLN
  • Stock Information
  • Founded
  • PTIX 1994
  • GNLN 2005
  • Country
  • PTIX United States
  • GNLN United States
  • Employees
  • PTIX N/A
  • GNLN N/A
  • Industry
  • PTIX Biotechnology: Pharmaceutical Preparations
  • GNLN Durable Goods
  • Sector
  • PTIX Health Care
  • GNLN Consumer Discretionary
  • Exchange
  • PTIX Nasdaq
  • GNLN Nasdaq
  • Market Cap
  • PTIX 3.7M
  • GNLN 3.2M
  • IPO Year
  • PTIX 2016
  • GNLN 2019
  • Fundamental
  • Price
  • PTIX $0.44
  • GNLN $1.50
  • Analyst Decision
  • PTIX
  • GNLN
  • Analyst Count
  • PTIX 0
  • GNLN 0
  • Target Price
  • PTIX N/A
  • GNLN N/A
  • AVG Volume (30 Days)
  • PTIX 377.2K
  • GNLN 130.6K
  • Earning Date
  • PTIX 11-14-2024
  • GNLN 11-15-2024
  • Dividend Yield
  • PTIX N/A
  • GNLN N/A
  • EPS Growth
  • PTIX N/A
  • GNLN N/A
  • EPS
  • PTIX N/A
  • GNLN N/A
  • Revenue
  • PTIX N/A
  • GNLN $21,605,000.00
  • Revenue This Year
  • PTIX N/A
  • GNLN $72.27
  • Revenue Next Year
  • PTIX N/A
  • GNLN $93.46
  • P/E Ratio
  • PTIX N/A
  • GNLN N/A
  • Revenue Growth
  • PTIX N/A
  • GNLN N/A
  • 52 Week Low
  • PTIX $0.43
  • GNLN $1.40
  • 52 Week High
  • PTIX $1.87
  • GNLN $21.80
  • Technical
  • Relative Strength Index (RSI)
  • PTIX 39.26
  • GNLN 40.22
  • Support Level
  • PTIX $0.43
  • GNLN $1.42
  • Resistance Level
  • PTIX $0.52
  • GNLN $1.64
  • Average True Range (ATR)
  • PTIX 0.05
  • GNLN 0.14
  • MACD
  • PTIX -0.01
  • GNLN 0.02
  • Stochastic Oscillator
  • PTIX 6.74
  • GNLN 21.62

About PTIX Protagenic Therapeutics Inc.

Protagenic Therapeutics Inc is a biopharmaceutical company focused on the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. It provides treatments for mood, anxiety, depression, and neurodegenerative disorders by using peptide-based and brain-active therapeutics. The company's lead compound, PT00114, is a synthetic form of Teneurin Carboxy-terminal Associated Peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. It has also created a portfolio of novel neuropeptides that are in various stages of development and preclinical evaluation for the treatment of mood disorders.

About GNLN Greenlane Holdings Inc.

Greenlane Holdings Inc is a distributor of vaporization products and consumption accessories in the United States. It offers a selection of stock-keeping units including vaporizers and parts, cleaning products, grinders and storage containers, pipes, rolling papers and customized lines of premium specialty packaging. The company markets and sells its products in both the business to business and business to consumer sectors of the marketplace. Its geographical segment includes the United States; Canada and Europe. It derives a majority of revenue from the United States.

Share on Social Networks: